Frequency and predictors of drug-eluting stent use in saphenous vein bypass graft percutaneous coronary interventions: A report from the american college of cardiology national cardiovascular data CathPCI registry

JACC: Cardiovascular Interventions

Volumn 3, Issue 10, 2010, Pages 1068-1073

  Brilakis, Emmanouil S ^a   Wang, Tracy Y ^c   Rao, Sunil V ^c   Banerjee, Subhash ^a   Goldman, Steven ^d   Shunk, Kendrick ^e   Kar, Biswajit ^b   Holmes Jr , David R ^f   Dai, David ^c   Chin, Chee T ^c   Harding, Tina M ^c   Roe, Matthew T ^c  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^d SOUTHERN ARIZONA VA HEALTH CARE SYSTEM   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f Mayo Clinic   (United States)

Author keywords

coronary artery bypass graft surgery; drugeluting stent(s); percutaneous coronary intervention; saphenous vein graft

Indexed keywords

ENOXAPARIN; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; HIRULOG;

ACUTE CORONARY SYNDROME; AGED; ARTICLE; BARE METAL STENT; CLINICAL PRACTICE; DRUG ELUTING STENT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT SAFETY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; REGISTER; SAPHENOUS VEIN GRAFT;

AGED; AGED, 80 AND OVER; ANGIOPLASTY, BALLOON, CORONARY; CHI-SQUARE DISTRIBUTION; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; DRUG-ELUTING STENTS; FEMALE; GRAFT OCCLUSION, VASCULAR; HOSPITAL MORTALITY; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; SAPHENOUS VEIN; SOCIETIES, MEDICAL; TREATMENT OUTCOME; UNITED STATES;

EID: 77958617618     PISSN: 19368798     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcin.2010.07.009     Document Type: Article

References (21)

1. E.S. Brilakis, B. Saeed, and S. Banerjee Drug-eluting stents in saphenous vein graft interventions: a systematic review EuroIntervention 5 2010 722 730
2. E.S. Brilakis, C. Lichtenwalter, and J.A. de Lemos A randomized controlled trial of a paclitaxel-eluting stent versus a similar bare-metal stent in saphenous vein graft lesions the SOS (Stenting of Saphenous Vein Grafts) trial J Am Coll Cardiol 53 2009 919 928
3. C. Lichtenwalter, J.A. de Lemos, and M. Roesle Clinical presentation and angiographic characteristics of saphenous vein graft failure after stenting: insights from the SOS (stenting of saphenous vein grafts) trial J Am Coll Cardiol Intv 2 2009 855 860
4. P. Vermeersch, P. Agostoni, and S. Verheye Randomized double-blind comparison of sirolimus-eluting stent versus bare-metal stent implantation in diseased saphenous vein grafts: six-month angiographic, intravascular ultrasound, and clinical follow-up of the RRISC trial J Am Coll Cardiol 48 2006 2423 2431
5. P. Vermeersch, P. Agostoni, S. Verheye DELAYED RRISC (Death and Events at Long-term follow-up AnalYsis: Extended Duration of the Reduction of Restenosis In Saphenous vein grafts with Cypher stent) Investigators Increased late mortality after sirolimus-eluting stents versus bare-metal stents in diseased saphenous vein grafts: results from the randomized DELAYED RRISC trial J Am Coll Cardiol 50 2007 261 267
6. R.G. Brindis, S. Fitzgerald, H.V. Anderson, R.E. Shaw, W.S. Weintraub, and J.F. Williams The American College of CardiologyNational Cardiovascular Data Registry (ACC-NCDR): building a national clinical data repository J Am Coll Cardiol 37 2001 2240 2245
7. E.D. Peterson, D. Dai, E.R. DeLong NCDR Registry Participants Contemporary mortality risk prediction for percutaneous coronary intervention: results from 588,398 procedures in the National Cardiovascular Data Registry J Am Coll Cardiol 55 2010 1923 1932
8. E.S. Brilakis, and P.B. Berger Should bare metal or drug-eluting stents be used during PCI of saphenous vein graft lesions: waiting for Godot? Catheter Cardiovasc Interv 72 2008 815 818
9. S.G. Ellis "Crying fire in a theater" or a "confirmatory sighting?" J Am Coll Cardiol 50 2007 268 269
10. B.R. Brodie, H. Wilson, T. Stuckey STENT Group Outcomes with drug-eluting versus bare-metal stents in saphenous vein graft intervention: results from the STENT (Strategic Transcatheter Evaluation of New Therapies) group J Am Coll Cardiol Intv 2 2009 1105 1112
11. S.B. King 3rd, S.C. Smith Jr., J.W. Hirshfeld Jr. American College of Cardiology, American Heart Association, Society for Cardiac Angiography and Interventions 2007 focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 51 2008 172 209
12. M. Pfisterer, H.P. Brunner-La Rocca, P.T. Buser BASKET-LATE Investigators Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents J Am Coll Cardiol 48 2006 2584 2591
13. J. Daemen, P. Wenaweser, and K. Tsuchida Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study Lancet 369 2007 667 678
14. G.W. Stone, J.W. Moses, and S.G. Ellis Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents N Engl J Med 356 2007 998 1008
15. A. Dibra, A. Kastrati, and F. Alfonso Effectiveness of drug-eluting stents in patients with bare-metal in-stent restenosis: meta-analysis of randomized trials J Am Coll Cardiol 49 2007 616 623 (Pubitemid 46177448)
16. G.W. Stone, A.J. Lansky, S.J. Pocock HORIZONS-AMI Trial Investigators Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction N Engl J Med 360 2009 1946 1959
17. S.K. Mehta, A.D. Frutkin, S. Milford-Beland American College of CardiologyNational Cardiovascular Data Registry Utilization of distal embolic protection in saphenous vein graft interventions (an analysis of 19,546 patients in the American College of CardiologyNational Cardiovascular Data Registry) Am J Cardiol 100 2007 1114 1118
18. S.C. Smith Jr., T.E. Feldman, J.W. Hirshfeld Jr. American College of Cardiology/American Heart Association Task Force on Practice Guidelines; ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention) J Am Coll Cardiol 47 2006 e1 e121
19. N. Badhey, C. Lichtenwalter, and J.A. de Lemos Contemporary use of embolic protection devices in saphenous vein graft interventions: insights from the SOS (Stenting Of Saphenous vein grafts) trial Catheter Cardiovasc Interv 76 2010 263 269
20. M. Roffi, D. Mukherjee, and D.P. Chew Lack of benefit from intravenous platelet glycoprotein IIb/IIIa receptor inhibition as adjunctive treatment for percutaneous interventions of aortocoronary bypass grafts: a pooled analysis of five randomized clinical trials Circulation 106 2002 3063 3067
21. A. Coolong, D.S. Baim, and R.E. Kuntz Saphenous vein graft stenting and major adverse cardiac events: a predictive model derived from a pooled analysis of 3,958 patients Circulation 117 2008 790 797